Financial News
Pra Health (NQ: PRAH )
144.78
USD
+1.97
(+1.38%)
Streaming Delayed Price
Updated: 4:05 PM EST, Mar 3, 2021
Add to My Watchlist
All news about Pra Health
Lifshitz Law Firm, P.C. Announces Investigation of APEX, CTB, GT, FRTA, PAND, PRAH, ICLR, PBCT and MBT
March 01, 2021
From PR Newswire
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of PRA Health Sciences, Inc. - PRAH
February 27, 2021
From PR Newswire
INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - PAND, PRAH, AEGN, PTVCA, CRHM, CBLI, AKER
February 25, 2021
From PR Newswire
PRA Health Sciences Larger Than S&P 500 Component Everest Re Group
February 25, 2021
Tags
Stocks
From Market News Video
Are These Top Health Care Stocks Worth Watching Ahead Of March?
February 25, 2021
Tags
Market News
From StockMarket.com
The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
February 25, 2021
From Benzinga
80 Biggest Movers From Yesterday
February 25, 2021
From Benzinga
Noteworthy Wednesday Option Activity: JEF, CR, PRAH
February 24, 2021
Tags
Stocks
From Market News Video
SHAREHOLDER ALERT: WeissLaw LLP Investigates PRA Health Sciences Inc.
February 24, 2021
From PR Newswire
Shareholder Alert: Ademi LLP Investigates whether PRA Health Sciences, Inc. has obtained a Fair Price in its transaction with Icon
February 24, 2021
From PR Newswire
Why Sunesis, Poseida, Salarius And PRA Health Are Rallying
February 24, 2021
From Benzinga
Why PRA Health Sciences Stock Is Soaring Today
February 24, 2021
From Motley Fool
(PRAH): Johnson Fistel Investigates the Proposed Sale of PRA Health; Are Shareholders Getting a Fair Deal?
February 24, 2021
From PR Newswire
Recap: PRA Health Sciences Q4 Earnings
February 24, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 24, 2021
From Benzinga
ICON Scoops Up PRA Health Sciences In $12B Deal
February 24, 2021
From Benzinga
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
February 20, 2021
From Benzinga
PRA Health Sciences to Report Fourth Quarter and Full Year 2020 Earnings
February 04, 2021
The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa
January 22, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
January 20, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.